✦ LIBER ✦

Crizotinib: A New Treatment Option for ALK-Positive Non-Small Cell Lung Cancer

✍ Scribed by O'Bryant, C. L.; Wenger, S. D.; Kim, M.; Thompson, L. A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Crizotinib for ALK-Rearranged Non-Small

✍ Gandhi, L.; Janne, P. A. 📂 Article 📅 2012 🏛 American Association for Cancer Research 🌐 English ⚖ 345 KB

Overcoming crizotinib resistance in ALK-

✍ Qi, Xiaolong; Ma, Wang; Li, Sen; Zhou, Caicun 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 188 KB

ALK-positive non-small cell lung cancer:

✍ Steuer, Conor E.; Ramalingam, Suresh S. 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 399 KB

Budget Impact Of Crizotinib For Alk-Posi

✍ Rosado-Buzzo, A.; Garcia-Mollinedo, L.; Luna-Casas, G.; Mould-Quevedo, J.F.; Gut 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

Crizotinib for the treatment of non-smal

✍ Timm, A.; Kolesar, J. M. 📂 Article 📅 2013 🏛 American Society of Health-System Pharmacists 🌐 English ⚖ 188 KB

ALK-Mutated Non-Small-Cell Lung Cancer:

✍ Cabezón-Gutiérrez, Luis; Khosravi-Shahi, Parham; Diaz-Muñoz-de-la-Espada, Victor 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 490 KB